DempoChem Logo
  1. HomeHome
  2. /ProductsProducts
  3. /Building BlocksBuilding Blocks
  4. /Chiral Building BlocksChiral Building Blocks
  5. /DeramciclaneDeramciclane
Chemical structure of CAS 120444-71-5

Deramciclane

In Stock•Starting at $464 for 1 mg•Purity ≥ 98.13%
CAS No.120444-71-5
MDL No.N/A
MFC20H31NO
MW301.50
InChI KeyQOBGWWQAMAPULA-RLLQIKCJSA-N
CUSTOM SYNTHESIS

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
1 mg98.13%$464In Stock
5 mg98.13%$1010In Stock
10 mg98.13%$1667In Stock
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.120444-71-5
Product NameDeramciclane
Heavy Atom Count22Rotatable Bond Count5
Atom Stereo Count3Bond Stereo Count0
HBA2HBD0
TPSA12.470 ŲCharge0
Exact Mass301.24056Complexity523.77
pKa2.025XLogP4.306

Related Articles

Studies related to this compound and its mechanism of action

Effect of the novel anxiolytic drug deramciclane on cytochrome P(450) 2D6 activity as measured by desipramine pharmacokinetics.

European journal of clinical pharmacology • Vol. 59, Issue 12 • 2004
PMID: 14730412DOI: 10.1007/s00228-003-0714-z

Comparison of deramciclane to benzodiazepine agonists in behavioural activity of mice and in alcohol drinking of alcohol-preferring rats.

Pharmacology, biochemistry, and behavior • Vol. 77, Issue 4 • 2004
PMID: 15099931DOI: 10.1016/j.pbb.2004.02.015

Pharmacokinetics of deramciclane and N-desmethylderamciclane after single and repeated oral doses in healthy volunteers.

International journal of clinical pharmacology and therapeutics • Vol. 42, Issue 8 • 2004
PMID: 15366325DOI: 10.5414/cpp42449

Effect of the novel anxiolytic drug deramciclane on the pharmacokinetics and pharmacodynamics of the CYP3A4 probe drug buspirone.

European journal of clinical pharmacology • Vol. 59, Issue 10 • 2003
PMID: 14566442DOI: 10.1007/s00228-003-0674-3

Documentation

Your Partner for
Complex Chemistry
logo
  • About Us
  • Perspectives
  • Products
  • Contact
  • Preclinical Development
  • Technologies
  • Custom Synthesis
Ready to start your project?

Provide your target molecule or project specifications to align on a tailored development and scale-up pathway with our scientific team.

START A PROJECT
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
logo

All products are supplied strictly for research and development use only and are not intended for human or veterinary administration, diagnostic use, or therapeutic use. Preclinical and related services are provided solely for research and development purposes and do not constitute clinical diagnosis, treatment, or veterinary care.

©2026 DempoChem. All Rights Reserved.
DHLFedExUPSPostNL
CLIENT PORTAL|TERMS AND CONDITIONS|PRIVACY POLICY|
  • Products
    • CDMO Compounds
    • API & Candidates
  • Services
    CDMO & Manufacturing
    • Custom Synthesis
    • Process Development
    • Lab To Pilot
    • Commercialization
    • Generic APIs
    CRO
    • Preclinical
    • Pharmacology & Efficacy
    • DMPK & Bioanalysis
    • Toxicology & Safety
    • Disease Models
    Technologies
    • High-Potent
    • Chiral Synthesis
    • Cloud Synthesis
    • Fermentation
    • Flow Chemistry
    • Biocatalysis
    Support
    • Regulatory Support
    • Supply Chain Solutions
  • About
  • Perspectives
  • Contact